Delving into the Latest Updates on New Cancer Cure-Bio Co.,Ltd. with Synapse

Overview

Tags

Neoplasms

Nervous System Diseases

Digestive System Disorders

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Neoplasms	4
Endocrinology and Metabolic Disease	3
Nervous System Diseases	1

Top 5 Drug Type	Count

Small molecule drug	4

Top 5 Target	Count

ACAA1 x SLC25A20	1
ACAA1(acetyl-CoA acyltransferase 1)	1
SLC25A20(solute carrier family 25 member 20)	1

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 29 Aug 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Preclinical

1

2

Phase 1

Phase 2

1

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

KN-510713 ( ACAA1 x SLC25A20 )	Metastatic Pancreatic Ductal Adenocarcinoma More	Phase 1/2
KN-713 ( ACAA1 )	Advanced Malignant Solid Neoplasm More	Phase 1
KN-510 ( SLC25A20 )	Advanced Malignant Solid Neoplasm More	Phase 1
KN-510714	Glioblastoma More	Preclinical